Download Files:
Envonalkib
SKU
HY-145566-10 mg
Category Reference compound
Tags Anaplastic lymphoma kinase (ALK), Cancer, Protein Tyrosine Kinase/RTK
$480 – $3,600
Products Details
Product Description
– Envonalkib is a potent and orally active inhibitor of ALK, with IC50s of 1.96 nM, 35.1 nM, and 61.3 nM for WT and mutated L1196M and G1269S-ALK. Envonalkib can be used for the research of non-small cell lung cancer[1].
Web ID
– HY-145566
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C24H26Cl2FN5O2
References
– [1]Feng G, et, al. Pyridine-substituted 2-aminopyridine protein kinase inhibitors. WO2016015676A1.
CAS Number
– 1621519-26-3
Molecular Weight
– 506.40
Compound Purity
– 99.73
SMILES
– COC1=CC(N2[C@H](CNCC2)C)=NC=C1C3=CN=C(N)C(O[C@@H](C4=C(C(F)=CC=C4Cl)Cl)C)=C3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Anaplastic lymphoma kinase (ALK)
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.